// company-profile
enGene Therapeutics Inc.
ENGNExchange: NasdaqSector: Biological Products, (No Diagnostic Substances)Inc.: Z4Filings: 56Insiders: 28
// activity-summary
No insider transactions in the last 30 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 30, 2026 | Nichols Alexander Julian | ENGN | Award | 195,000 | $0.00 | $0K |
| Jan 30, 2026 | Daws D. Ryan | ENGN | Award | 220,000 | $0.00 | $0K |
| Jan 30, 2026 | Connolly Joan | ENGN | Award | 195,000 | $0.00 | $0K |
| Jan 30, 2026 | Giguere Lee | ENGN | Award | 195,000 | $0.00 | $0K |
| Jan 30, 2026 | Cooper Ronald Harold Wilfred | ENGN | Award | 801,000 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →